25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Starpharma Holdings Ltd
Buy, Hold or Sell?

Let's analyze Starpharma together

I guess you are interested in Starpharma Holdings Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Starpharma Holdings Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Starpharma Holdings Ltd

I send you an email if I find something interesting about Starpharma Holdings Ltd.

1. Quick Overview

1.1. Quick analysis of Starpharma (30 sec.)










1.2. What can you expect buying and holding a share of Starpharma? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.04
Expected worth in 1 year
$0.00
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.04
Return On Investment
-6.3%

For what price can you sell your share?

Current Price per Share
$0.70
Expected price per share
$0.52 - $0.76
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Starpharma (5 min.)




Live pricePrice per Share (EOD)
$0.70
Intrinsic Value Per Share
$-0.46 - $0.50
Total Value Per Share
$-0.41 - $0.54

2.2. Growth of Starpharma (5 min.)




Is Starpharma growing?

Current yearPrevious yearGrowGrow %
How rich?$18.4m$22.9m-$4.4m-23.8%

How much money is Starpharma making?

Current yearPrevious yearGrowGrow %
Making money-$5.3m-$10.2m$4.9m91.5%
Net Profit Margin-98.5%-532.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Starpharma (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#561 / 959

Most Revenue
#332 / 959

Most Profit
#450 / 959

Most Efficient
#451 / 959
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Starpharma?

Welcome investor! Starpharma's management wants to use your money to grow the business. In return you get a share of Starpharma.

First you should know what it really means to hold a share of Starpharma. And how you can make/lose money.

Speculation

The Price per Share of Starpharma is $0.7. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Starpharma.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Starpharma, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.04. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Starpharma.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-1.9%-0.01-1.9%-0.03-3.6%-0.02-3.5%-0.08-12.0%
Usd Book Value Change Per Share-0.01-1.6%-0.01-1.6%-0.02-3.2%-0.01-0.9%-0.05-6.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-1.6%-0.01-1.6%-0.02-3.2%-0.01-0.9%-0.05-6.8%
Usd Price Per Share0.63-0.63-2.10-5.36-6.16-
Price to Earnings Ratio-48.37--48.37--83.80--195.77--149.91-
Price-to-Total Gains Ratio-57.59--57.59--94.82--105.17--157.99-
Price to Book Ratio14.05-14.05-37.64-74.12-66.07-
Price-to-Total Gains Ratio-57.59--57.59--94.82--105.17--157.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.7
Number of shares1428
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.01-0.01
Usd Total Gains Per Share-0.01-0.01
Gains per Quarter (1428 shares)-15.62-8.62
Gains per Year (1428 shares)-62.49-34.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-62-720-34-44
20-125-1340-69-78
30-187-1960-103-112
40-250-2580-138-146
50-312-3200-172-180
60-375-3820-207-214
70-437-4440-241-248
80-500-5060-276-282
90-562-5680-310-316
100-625-6300-345-350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%1.010.00.09.1%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.07.00.030.0%4.07.00.036.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.011.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.07.00.030.0%4.07.00.036.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Starpharma Holdings Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.011-0.0110%-0.022+102%-0.006-45%-0.047+333%
Book Value Per Share--0.0450.0450%0.056-20%0.067-33%0.205-78%
Current Ratio--4.9414.9410%3.256+52%5.277-6%6.728-27%
Debt To Asset Ratio--0.2360.2360%0.332-29%0.2370%0.181+31%
Debt To Equity Ratio--0.3090.3090%0.496-38%0.319-3%0.231+34%
Dividend Per Share----0%-0%-0%-0%
Eps---0.013-0.0130%-0.025+92%-0.024+87%-0.084+545%
Free Cash Flow Per Share---0.011-0.0110%-0.023+101%-0.020+78%-0.070+522%
Free Cash Flow To Equity Per Share---0.019-0.0190%-0.024+26%-0.006-69%0.024-178%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.499--------
Intrinsic Value_10Y_min---0.460--------
Intrinsic Value_1Y_max---0.004--------
Intrinsic Value_1Y_min---0.065--------
Intrinsic Value_3Y_max--0.029--------
Intrinsic Value_3Y_min---0.179--------
Intrinsic Value_5Y_max--0.112--------
Intrinsic Value_5Y_min---0.277--------
Market Cap29267490.000-788%259794736.740259794736.7400%862035461.700-70%2127788983.640-88%2005320895.282-87%
Net Profit Margin---0.985-0.9850%-5.321+440%-4.633+370%-4.885+396%
Operating Margin----0%-5.3670%-4.6690%-5.7800%
Operating Ratio--0.0760.0760%0.381-80%0.328-77%2.936-97%
Pb Ratio15.608+10%14.04714.0470%37.641-63%74.121-81%66.068-79%
Pe Ratio-53.745-11%-48.370-48.3700%-83.801+73%-195.772+305%-149.906+210%
Price Per Share0.700+10%0.6300.6300%2.100-70%5.362-88%6.155-90%
Price To Free Cash Flow Ratio-62.104-11%-55.894-55.8940%-92.587+66%-248.171+344%-244.925+338%
Price To Total Gains Ratio-63.984-11%-57.586-57.5860%-94.819+65%-105.167+83%-157.990+174%
Quick Ratio--0.9150.9150%0.543+69%0.762+20%0.770+19%
Return On Assets---0.222-0.2220%-0.300+35%-0.282+27%-0.257+16%
Return On Equity---0.290-0.2900%-0.449+55%-0.372+28%-0.322+11%
Total Gains Per Share---0.011-0.0110%-0.022+102%-0.006-45%-0.047+333%
Usd Book Value--18494704.80018494704.8000%22901307.000-19%26963222.000-31%29789046.039-38%
Usd Book Value Change Per Share---0.011-0.0110%-0.022+102%-0.006-45%-0.047+333%
Usd Book Value Per Share--0.0450.0450%0.056-20%0.067-33%0.205-78%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.013-0.0130%-0.025+92%-0.024+87%-0.084+545%
Usd Free Cash Flow---4648014.800-4648014.8000%-9310501.200+100%-8048051.440+73%-8799417.633+89%
Usd Free Cash Flow Per Share---0.011-0.0110%-0.023+101%-0.020+78%-0.070+522%
Usd Free Cash Flow To Equity Per Share---0.019-0.0190%-0.024+26%-0.006-69%0.024-178%
Usd Market Cap29267490.000-788%259794736.740259794736.7400%862035461.700-70%2127788983.640-88%2005320895.282-87%
Usd Price Per Share0.700+10%0.6300.6300%2.100-70%5.362-88%6.155-90%
Usd Profit---5370937.000-5370937.0000%-10286676.400+92%-9783722.520+82%-8846475.930+65%
Usd Revenue--5452504.2005452504.2000%1933274.200+182%3123365.960+75%2493783.309+119%
Usd Total Gains Per Share---0.011-0.0110%-0.022+102%-0.006-45%-0.047+333%
 EOD+3 -5MRQTTM+0 -0YOY+24 -85Y+17 -1510Y+19 -13

3.3 Fundamental Score

Let's check the fundamental score of Starpharma Holdings Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-53.745
Price to Book Ratio (EOD)Between0-115.608
Net Profit Margin (MRQ)Greater than0-0.985
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.915
Current Ratio (MRQ)Greater than14.941
Debt to Asset Ratio (MRQ)Less than10.236
Debt to Equity Ratio (MRQ)Less than10.309
Return on Equity (MRQ)Greater than0.15-0.290
Return on Assets (MRQ)Greater than0.05-0.222
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Starpharma Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.483
Ma 20Greater thanMa 500.644
Ma 50Greater thanMa 1000.651
Ma 100Greater thanMa 2000.621
OpenGreater thanClose0.700
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Starpharma Holdings Ltd

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It is also involved in the development of dendrimer enhanced product (DEP) delivery platform, consisting of DEP SN38 for the treatment of ovarian and colorectal cancer that is in Phase II clinical trial; DEP cabazitaxel for prostate and ovarian cancer treatment that is in Phase II clinical trial; and DEP docetaxel to treat pancreatic and other cancers that is in Phase II clinical trial. In addition, the company is developing DEP HER2 radiodiagnostic and DEP HER2 ADC to treat solid tumors; SPL7013 for vaginal gel; and DEP HER2 radiodiagnostic. It has a collaboration agreement with Medicxi to develop petalion therapeutics, a novel cancer therapy using Starpharma's dendrimer technology. Starpharma Holdings Limited was incorporated in 1997 and is headquartered in Abbotsford, Australia.

Fundamental data was last updated by Penke on 2024-11-07 04:10:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Starpharma earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Starpharma to the Biotechnology industry mean.
  • A Net Profit Margin of -98.5% means that $-0.99 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Starpharma Holdings Ltd:

  • The MRQ is -98.5%. The company is making a huge loss. -2
  • The TTM is -98.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-98.5%TTM-98.5%0.0%
TTM-98.5%YOY-532.1%+433.6%
TTM-98.5%5Y-463.3%+364.8%
5Y-463.3%10Y-488.5%+25.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-98.5%-133.6%+35.1%
TTM-98.5%-204.9%+106.4%
YOY-532.1%-207.4%-324.7%
5Y-463.3%-353.5%-109.8%
10Y-488.5%-466.1%-22.4%
4.3.1.2. Return on Assets

Shows how efficient Starpharma is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Starpharma to the Biotechnology industry mean.
  • -22.2% Return on Assets means that Starpharma generated $-0.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Starpharma Holdings Ltd:

  • The MRQ is -22.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -22.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.2%TTM-22.2%0.0%
TTM-22.2%YOY-30.0%+7.8%
TTM-22.2%5Y-28.2%+6.0%
5Y-28.2%10Y-25.7%-2.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.2%-10.8%-11.4%
TTM-22.2%-11.8%-10.4%
YOY-30.0%-11.0%-19.0%
5Y-28.2%-12.6%-15.6%
10Y-25.7%-14.4%-11.3%
4.3.1.3. Return on Equity

Shows how efficient Starpharma is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Starpharma to the Biotechnology industry mean.
  • -29.0% Return on Equity means Starpharma generated $-0.29 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Starpharma Holdings Ltd:

  • The MRQ is -29.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -29.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.0%TTM-29.0%0.0%
TTM-29.0%YOY-44.9%+15.9%
TTM-29.0%5Y-37.2%+8.1%
5Y-37.2%10Y-32.2%-5.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.0%-13.5%-15.5%
TTM-29.0%-15.9%-13.1%
YOY-44.9%-13.5%-31.4%
5Y-37.2%-18.6%-18.6%
10Y-32.2%-19.0%-13.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Starpharma Holdings Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Starpharma is operating .

  • Measures how much profit Starpharma makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Starpharma to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Starpharma Holdings Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-536.7%+536.7%
TTM-5Y-466.9%+466.9%
5Y-466.9%10Y-578.0%+111.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--277.1%+277.1%
TTM--312.9%+312.9%
YOY-536.7%-222.0%-314.7%
5Y-466.9%-385.5%-81.4%
10Y-578.0%-495.6%-82.4%
4.3.2.2. Operating Ratio

Measures how efficient Starpharma is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.08 means that the operating costs are $0.08 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Starpharma Holdings Ltd:

  • The MRQ is 0.076. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.076. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.076TTM0.0760.000
TTM0.076YOY0.381-0.305
TTM0.0765Y0.328-0.251
5Y0.32810Y2.936-2.609
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0762.842-2.766
TTM0.0763.198-3.122
YOY0.3813.301-2.920
5Y0.3284.800-4.472
10Y2.9366.530-3.594
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Starpharma Holdings Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Starpharma is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.94 means the company has $4.94 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Starpharma Holdings Ltd:

  • The MRQ is 4.941. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.941. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.941TTM4.9410.000
TTM4.941YOY3.256+1.685
TTM4.9415Y5.277-0.336
5Y5.27710Y6.728-1.451
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9413.788+1.153
TTM4.9413.923+1.018
YOY3.2564.711-1.455
5Y5.2775.959-0.682
10Y6.7286.278+0.450
4.4.3.2. Quick Ratio

Measures if Starpharma is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Starpharma to the Biotechnology industry mean.
  • A Quick Ratio of 0.91 means the company can pay off $0.91 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Starpharma Holdings Ltd:

  • The MRQ is 0.915. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.915. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.915TTM0.9150.000
TTM0.915YOY0.543+0.372
TTM0.9155Y0.762+0.153
5Y0.76210Y0.770-0.008
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9153.381-2.466
TTM0.9153.526-2.611
YOY0.5434.682-4.139
5Y0.7625.922-5.160
10Y0.7706.458-5.688
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Starpharma Holdings Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Starpharma assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Starpharma to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.24 means that Starpharma assets are financed with 23.6% credit (debt) and the remaining percentage (100% - 23.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Starpharma Holdings Ltd:

  • The MRQ is 0.236. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.236. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.236TTM0.2360.000
TTM0.236YOY0.332-0.095
TTM0.2365Y0.237-0.001
5Y0.23710Y0.181+0.056
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2360.338-0.102
TTM0.2360.347-0.111
YOY0.3320.310+0.022
5Y0.2370.365-0.128
10Y0.1810.381-0.200
4.5.4.2. Debt to Equity Ratio

Measures if Starpharma is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Starpharma to the Biotechnology industry mean.
  • A Debt to Equity ratio of 30.9% means that company has $0.31 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Starpharma Holdings Ltd:

  • The MRQ is 0.309. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.309. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.309TTM0.3090.000
TTM0.309YOY0.496-0.187
TTM0.3095Y0.319-0.010
5Y0.31910Y0.231+0.088
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3090.387-0.078
TTM0.3090.437-0.128
YOY0.4960.375+0.121
5Y0.3190.450-0.131
10Y0.2310.489-0.258
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Starpharma generates.

  • Above 15 is considered overpriced but always compare Starpharma to the Biotechnology industry mean.
  • A PE ratio of -48.37 means the investor is paying $-48.37 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Starpharma Holdings Ltd:

  • The EOD is -53.745. Based on the earnings, the company is expensive. -2
  • The MRQ is -48.370. Based on the earnings, the company is expensive. -2
  • The TTM is -48.370. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-53.745MRQ-48.370-5.374
MRQ-48.370TTM-48.3700.000
TTM-48.370YOY-83.801+35.431
TTM-48.3705Y-195.772+147.402
5Y-195.77210Y-149.906-45.866
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-53.745-2.384-51.361
MRQ-48.370-2.428-45.942
TTM-48.370-2.991-45.379
YOY-83.801-3.440-80.361
5Y-195.772-6.006-189.766
10Y-149.906-6.278-143.628
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Starpharma Holdings Ltd:

  • The EOD is -62.104. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -55.894. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -55.894. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-62.104MRQ-55.894-6.210
MRQ-55.894TTM-55.8940.000
TTM-55.894YOY-92.587+36.694
TTM-55.8945Y-248.171+192.278
5Y-248.17110Y-244.925-3.246
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-62.104-3.160-58.944
MRQ-55.894-3.222-52.672
TTM-55.894-3.516-52.378
YOY-92.587-4.582-88.005
5Y-248.171-8.076-240.095
10Y-244.925-8.950-235.975
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Starpharma is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 14.05 means the investor is paying $14.05 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Starpharma Holdings Ltd:

  • The EOD is 15.608. Based on the equity, the company is expensive. -2
  • The MRQ is 14.047. Based on the equity, the company is expensive. -2
  • The TTM is 14.047. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD15.608MRQ14.047+1.561
MRQ14.047TTM14.0470.000
TTM14.047YOY37.641-23.594
TTM14.0475Y74.121-60.074
5Y74.12110Y66.068+8.053
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD15.6081.964+13.644
MRQ14.0471.983+12.064
TTM14.0472.197+11.850
YOY37.6412.404+35.237
5Y74.1213.596+70.525
10Y66.0684.223+61.845
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets36,814
Total Liabilities8,698
Total Stockholder Equity28,116
 As reported
Total Liabilities 8,698
Total Stockholder Equity+ 28,116
Total Assets = 36,814

Assets

Total Assets36,814
Total Current Assets32,919
Long-term Assets3,895
Total Current Assets
Cash And Cash Equivalents 23,360
Net Receivables 6,095
Inventory 2,408
Total Current Assets  (as reported)32,919
Total Current Assets  (calculated)31,863
+/- 1,056
Long-term Assets
Property Plant Equipment 3,895
Long-term Assets  (as reported)3,895
Long-term Assets  (calculated)3,895
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,662
Long-term Liabilities2,036
Total Stockholder Equity28,116
Total Current Liabilities
Short Long Term Debt 775
Accounts payable 2,725
Total Current Liabilities  (as reported)6,662
Total Current Liabilities  (calculated)3,500
+/- 3,162
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,753
Long-term Liabilities  (as reported)2,036
Long-term Liabilities  (calculated)2,753
+/- 717
Total Stockholder Equity
Total Stockholder Equity (as reported)28,116
Total Stockholder Equity (calculated)0
+/- 28,116
Other
Capital Stock240,750
Common Stock Shares Outstanding 412,373
Net Invested Capital 28,891
Net Working Capital 26,257
Property Plant and Equipment Gross 7,287



6.2. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-30
> Total Assets 
36,862
49,430
59,039
66,591
58,511
48,859
39,078
73,238
66,175
52,086
36,814
36,81452,08666,17573,23839,07848,85958,51166,59159,03949,43036,862
   > Total Current Assets 
28,598
39,069
50,276
65,678
57,453
47,809
36,676
70,755
60,658
47,122
32,919
32,91947,12260,65870,75536,67647,80957,45365,67850,27639,06928,598
       Cash And Cash Equivalents 
24,028
34,356
45,972
61,188
51,319
41,251
30,054
60,500
49,918
35,180
23,360
23,36035,18049,91860,50030,05441,25151,31961,18845,97234,35624,028
       Net Receivables 
4,416
4,467
3,938
4,206
6,097
6,080
5,905
7,905
7,285
7,857
6,095
6,0957,8577,2857,9055,9056,0806,0974,2063,9384,4674,416
   > Long-term Assets 
0
0
8,763
913
1,058
1,050
2,402
2,483
5,517
4,964
3,895
3,8954,9645,5172,4832,4021,0501,0589138,76300
       Property Plant Equipment 
509
1,013
690
913
1,058
1,050
2,402
2,483
5,517
4,964
3,895
3,8954,9645,5172,4832,4021,0501,0589136901,013509
       Goodwill 
1,581
2,159
2,005
0
0
0
0
0
0
0
0
000000002,0052,1591,581
       Intangible Assets 
6,174
7,188
6,068
0
0
0
0
0
0
0
0
000000006,0687,1886,174
> Total Liabilities 
3,911
7,601
9,615
5,607
5,234
6,464
7,752
10,938
17,782
17,271
8,698
8,69817,27117,78210,9387,7526,4645,2345,6079,6157,6013,911
   > Total Current Liabilities 
3,844
7,539
9,575
5,521
5,164
6,426
6,697
10,429
10,231
14,473
6,662
6,66214,47310,23110,4296,6976,4265,1645,5219,5757,5393,844
       Short-term Debt 
75
0
0
0
0
0
0
0
0
0
0
000000000075
       Short Long Term Debt 
75
0
0
0
0
0
0
0
0
4,778
775
7754,7780000000075
       Accounts payable 
2,586
6,104
8,210
4,034
3,023
4,098
4,394
6,711
6,762
6,615
2,725
2,7256,6156,7626,7114,3944,0983,0234,0348,2106,1042,586
       Other Current Liabilities 
572
586
718
647
1,185
1,246
515
1,655
1,435
1,055
0
01,0551,4351,6555151,2461,185647718586572
   > Long-term Liabilities 
0
0
40
86
70
38
1,055
509
7,551
2,798
2,036
2,0362,7987,5515091,0553870864000
       Capital Lease Obligations 
0
0
18
70
49
26
1,574
1,167
4,189
3,494
2,753
2,7533,4944,1891,1671,5742649701800
       Long-term Liabilities Other 
0
0
0
39
0
0
0
0
0
0
0
000000039000
> Total Stockholder Equity
32,951
41,829
49,424
60,984
53,277
42,395
31,326
62,300
48,393
34,815
28,116
28,11634,81548,39362,30031,32642,39553,27760,98449,42441,82932,951
   Common Stock
140,349
179,178
193,512
193,549
193,583
193,621
193,661
240,630
240,669
240,715
0
0240,715240,669240,630193,661193,621193,583193,549193,512179,178140,349
   Retained Earnings -242,364-234,199-218,561-202,407-182,675-168,001-153,746-143,461-153,875-146,119-112,250
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
4,852
8,769
9,787
10,896
13,440
16,775
20,340
24,077
26,285
28,299
0
028,29926,28524,07720,34016,77513,44010,8969,7878,7694,852



6.3. Balance Sheets

Currency in AUD. All numbers in thousands.




6.4. Cash Flows

Currency in AUD. All numbers in thousands.




6.5. Income Statements

Currency in AUD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue8,289
Cost of Revenue-632
Gross Profit7,6577,657
 
Operating Income (+$)
Gross Profit7,657
Operating Expense-0
Operating Income-10,7477,657
 
Operating Expense (+$)
Research Development10,053
Selling General Administrative3,572
Selling And Marketing Expenses0
Operating Expense013,625
 
Net Interest Income (+$)
Interest Income1,467
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,467
 
Pretax Income (+$)
Operating Income-10,747
Net Interest Income1,467
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,165-10,747
EBIT - interestExpense = 0
-8,165
-8,165
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-8,165
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-8,165
Tax Provision-0
Net Income From Continuing Ops-8,165-8,165
Net Income-8,165
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-1,467
 

Technical Analysis of Starpharma
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Starpharma. The general trend of Starpharma is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Starpharma's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Starpharma Holdings Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.7 < 0.76 < 0.76.

The bearish price targets are: 0.56 > 0.54 > 0.52.

Tweet this
Starpharma Holdings Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Starpharma Holdings Ltd. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Starpharma Holdings Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Starpharma Holdings Ltd. The current macd is 0.00864709.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Starpharma price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Starpharma. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Starpharma price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Starpharma Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) ChartStarpharma Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Starpharma Holdings Ltd. The current adx is 18.41.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Starpharma shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Starpharma Holdings Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Starpharma Holdings Ltd. The current sar is 0.56176288.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Starpharma Holdings Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Starpharma Holdings Ltd. The current rsi is 59.48. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Starpharma Holdings Ltd Daily Relative Strength Index (RSI) ChartStarpharma Holdings Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Starpharma Holdings Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Starpharma price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Starpharma Holdings Ltd Daily Stochastic Oscillator ChartStarpharma Holdings Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Starpharma Holdings Ltd. The current cci is 123.10.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Starpharma Holdings Ltd Daily Commodity Channel Index (CCI) ChartStarpharma Holdings Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Starpharma Holdings Ltd. The current cmo is 32.05.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Starpharma Holdings Ltd Daily Chande Momentum Oscillator (CMO) ChartStarpharma Holdings Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Starpharma Holdings Ltd. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Starpharma Holdings Ltd Daily Williams %R ChartStarpharma Holdings Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Starpharma Holdings Ltd.

Starpharma Holdings Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Starpharma Holdings Ltd. The current atr is 0.02314718.

Starpharma Holdings Ltd Daily Average True Range (ATR) ChartStarpharma Holdings Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Starpharma Holdings Ltd. The current obv is -102,900.

Starpharma Holdings Ltd Daily On-Balance Volume (OBV) ChartStarpharma Holdings Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Starpharma Holdings Ltd. The current mfi is 44.35.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Starpharma Holdings Ltd Daily Money Flow Index (MFI) ChartStarpharma Holdings Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Starpharma Holdings Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Starpharma Holdings Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Starpharma Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.483
Ma 20Greater thanMa 500.644
Ma 50Greater thanMa 1000.651
Ma 100Greater thanMa 2000.621
OpenGreater thanClose0.700
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Starpharma with someone you think should read this too:
  • Are you bullish or bearish on Starpharma? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Starpharma? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Starpharma Holdings Ltd

I send you an email if I find something interesting about Starpharma Holdings Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Starpharma Holdings Ltd.

Receive notifications about Starpharma Holdings Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.